Clinical trials
Not yet recruiting Phase 1 Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanjing Miracle Biotechnology Co., Ltd. | 2 |
| Zhejiang University | 2 |
| Kousai Bio Co., Ltd. | 1 |
| Orum Therapeutics USA, Inc. | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| Regeneron Pharmaceuticals | 1 |
| Ruijin Hospital | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| Sichuan University | 1 |
| Suzhou Immunofoco Biotechnology Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 18 |
| Recurrence | 4 |
| Communicable Diseases | 1 |
| Leukemia, Biphenotypic, Acute | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Myelodysplastic Syndromes | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.